Clinical trial
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers…
NCT00496288 · Assaf-Harofeh Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00496288 |
|---|---|
| Title | Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer |
| Official title | Phase II Multicenter Clinical Trial of Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Collaborators | Rambam Health Care Campus Tel-Aviv Sourasky Medical Center Sheba Medical Center Soroka University Medical Center Western Galilee Hospital-Nahariya Rabin Medical Center |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Radiation |
| Interventions | Prophylactic radiation to the contralateral breast |
| Enrollment | 240 |
| Start date | Mar 1, 2008 |
| Primary completion | Mar 1, 2023 |
| First posted | Jul 4, 2007 |
| Last update posted | Apr 5, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: